MEDICLINIC INTERNATIONAL LIMITED - Dealings in securities by a director of a major subsidiary of the Company

Dealings in securities by a director of a major subsidiary of the Company

Mediclinic International Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
JSE Share Code: MDC
NSX Share Code: MCI
("Mediclinic" or "the Company")

DEALINGS IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY OF THE
COMPANY

In compliance with the Listings Requirements of the JSE Limited
("JSE"), the following information is disclosed relating to the
sale of ordinary shares in Mediclinic by a director of a major
subsidiary of the Company:

Director                     :   Mr B Valodia
Company                      :   Mediclinic Southern Africa (Pty)
                                 Ltd (a major subsidiary of Mediclinic)
Date of transaction          :   5 March 2015
Nature of transaction        :   On market sale of securities
Class of securities          :   Ordinary shares
Number of securities         :   5 500
Selling price                :   VWAP: R126.05 per share
                                 Lowest price: R126.02 per share
                                 Highest price: R126.33 per share
Total value of transaction   :   R693 302.92
Nature of interest           :   Direct beneficial
Clearance obtained           :   Yes

Stellenbosch
5 March 2015

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

Date: 05/03/2015 02:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.